2WARD C, LI X, WANG N, et al. Salmeterol reduces BAL IL-8 levels in asthmatics on low dose inhaled corticosteroids [J].Eur Resoir J, 1998,28:380S.
3OTTONELLO L, MORONE P, DAPINO P, et al. Inhibitory effect of salmeterd on the respiratory burst of adherent human neutrophils [J]. Clin Exp Immunol , 1996,106:97 - 102.
4IEE E, SMITH J, ROBERTSON T, et al. Salmetetol and inhibitors of phosphodiesterase 4 (PDE - 4) induce apoptosia in neutrophils from asthmatics: β - adrenergic receptor - mediated salmeterol activity and additive effects with PDE - 4 inhibitors[J]. Am J Respir Cell Mol Biol, 1999.159:A329.
5DOWLING R B, JOHNSON M, COLE P J, et al. Effect of fluticasone propionate and salmeterol on pseudomonas aeruginosa infection of the respiratory mucosa in vitro [J]. Eur Respir J,1999.14: 363-369.
6ANZUETO A, JOBRAN A, OHAR JA, et al. Effects of aerosolized surfactant in patients with stable chronic bronchitis: a prospective randamized oontrolled trial [J]. JAMA, 1997,278:1 426-1 431.
7National Institutes of Health, National Heart, Lung, and Blood Institue. Global initiative for asthma - Global strategy for asthma management and prevention[M]. NIH Publication,2002. 108.
8MAHLER D A, DONOHUE J F, BARBEE R A, et al. Efficacy of salmeterol xinafoate in the treatment of ODPD [ J ]. Chest,1999,115:957-965.
9BOYD G, MORICE A H, POUNSFORD J C, et ad. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (ODPD) [J]. Eur Respir J, 1997,10:815 -821.
10VAN NOORD J, DE MUNCK D, BANTJE T, et al. Efficacy and safety of salmeterol and ipratropitan bronide in patients with chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 1998,157: A799.
